ACVR2B

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ACVR2B mutation is significantly associated with the drug of many other genes, with 15 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ACVR2B-associated genes across cancer lineages are Niraparib, CDK9_5038, and 729189. Each is linked with ACVR2B in more than 1 cancer types. Because this analysis shows association rather than direction, both ACVR2B-to-partner and partner-to-ACVR2B results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Niraparib grouped by ACVR2B-low versus ACVR2B-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ACVR2B→partner) and Y-score (partner→ACVR2B) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINENiraparib →+0.460+2.678.008.03731
LARGE_INTESTINECDK9_5038 →+0.589+2.906.032.03321
LARGE_INTESTINE729189 →+0.336+2.649.007.04621
LARGE_INTESTINENutlin-3a (-) →+0.872+2.646.016.04711
LARGE_INTESTINEAZD5991 →+1.228+2.649<.001.04611
LARGE_INTESTINEGSK2256098C →+0.425+2.906.005.03311
Each partner links to its Q-omics profile. Showing the 6 strongest of 15 associations by consensus.

Niraparib by ACVR2B expression — LARGE_INTESTINE

Box plot of Niraparib in ACVR2B-low vs ACVR2B-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration